PAL Parallel Mining Corp

Sirona Biochem Corp. (TSX VENTURE:SBM)(OTCQX:SRBCF)(FRANKFURT:ZSB) announced
today its stock is now trading on OTCQX(R), the highest OTC marketplace in the
U.S., under the symbol SRBCF. Investors can find current financial disclosures
and Real-Time Level 2 quotes for the Company on www.otcmarkets.com.


"The visibility and quality of the OTCQX market will help expand Sirona
Biochem's investor reach in the U.S.," said Neil Belenkie, Chief Executive
Officer of Sirona Biochem. "International interest in Sirona Biochem has
increased and the OTCQX marketplace provides an accessible platform for U.S.
investors to buy and trade our stock," he added.


"OTCQX companies demonstrate their commitment to providing superior information
to investors and maintaining the highest quality standards," said R. Cromwell
Coulson, President and Chief Executive Officer of OTC Markets Group. "We are
pleased to welcome Sirona Biochem to OTCQX."


Merriman Capital, Inc. will serve as Sirona Biochem's Principal American Liaison
("PAL") on OTCQX, responsible for providing guidance on OTCQX requirements.


OTC Markets Group Inc. (OTCQX:OTCM) operates the world's largest Open,
Transparent and Connected financial marketplace platform, delivering price
transparency in almost 10,000 OTC securities. The OTC Link(R) ATS directly links
broker-dealers that provide liquidity and execution services. We organize the
wide spectrum of OTC-traded securities into three marketplaces to inform
investors of opportunities and risks - OTCQX(R) - The Intelligent Marketplace
for the Best OTC Companies; OTCQB(R) - The Venture Marketplace; and OTC Pink(R)
- The Open Marketplace. Our financial marketplace platform enables smarter
trading through any broker at the best possible price, and empowers companies to
improve the quality and availability of information for their investors. To
learn more about our Open, Transparent and Connected financial marketplaces,
visit www.otcmarkets.com.


About Sirona Biochem Corp.

Sirona Biochem is a biotechnology company developing diabetes therapeutics, skin
depigmenting and anti-aging agents for cosmetic use, biological ingredients and
cancer vaccine antigens. The company utilizes a proprietary chemistry technique
to improve pharmaceutical properties of carbohydrate-based molecules. For more
information visit www.sironabiochem.com.


Sirona Biochem cautions you that statements included in this press release that
are not a description of historical facts may be forward-looking statements.
Forward-looking statements are only predictions based upon current expectations
and involve known and unknown risks and uncertainties. You are cautioned not to
place undue reliance on these forward-looking statements, which speak only as of
the date of release of the relevant information, unless explicitly stated
otherwise. Actual results, performance or achievement could differ materially
from those expressed in, or implied by, Sirona Biochem's forward-looking
statements due to the risks and uncertainties inherent in Sirona Biochem's
business including, without limitation, statements about: the progress and
timing of its clinical trials; difficulties or delays in development, testing,
obtaining regulatory approval, producing and marketing its products; unexpected
adverse side effects or inadequate therapeutic efficacy of its products that
could delay or prevent product development or commercialization; the scope and
validity of patent protection for its products; competition from other
pharmaceutical or biotechnology companies; and its ability to obtain additional
financing to support its operations. Sirona Biochem does not assume any
obligation to update any forward-looking statements except as required by law.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Sirona Biochem Corp.
Julie Jang
Director, Communications
604.282.6065
jjang@sironabiochem.com
www.sironabiochem.com

Parallel Mining (TSXV:PAL)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024

Parallel Mining (TSXV:PAL)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024